Scinovex
Subscribe
M

Marja‐Riitta Taskinen

University of HelsinkiORCID https://orcid.org/0000-0002-6229-3588
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—

Top Publications

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
European Heart Journal20198,581 citations
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
European Heart Journal20198,581 citations
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Atherosclerosis20194,829 citations
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Diabetes Care20014,771 citations
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
European Heart Journal20173,678 citations
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
European Heart Journal20113,538 citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
European Heart Journal20163,169 citations
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
European Heart Journal20132,699 citations
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Nature Genetics20222,354 citations
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
European Heart Journal20131,949 citations
Lipoprotein(a) as a cardiovascular risk factor: current status
European Heart Journal20101,758 citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Atherosclerosis20161,581 citations
Diabetic dyslipidaemia: from basic research to clinical practice*
Diabetologia2003868 citationsFirst authorCorresponding
Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
Arteriosclerosis Thrombosis and Vascular Biology2008799 citations
ESC/EAS Guidelines for the management of dyslipidaemias
Atherosclerosis2011704 citations
Overproduction of large VLDL particles is driven by increased liver fat content in man
Diabetologia2006683 citations
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Atherosclerosis2015431 citationsFirst authorCorresponding